{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "TOLERANZIA AB", "longName": "Toleranzia AB", "messageBoardId": "finmb_228444470", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "marketState": "REGULAR", "epsTrailingTwelveMonths": -0.0, "sharesOutstanding": 110315000, "fiftyDayAverage": 0.067808, "fiftyDayAverageChange": -0.011408001, "fiftyDayAverageChangePercent": -0.16823974, "twoHundredDayAverage": 0.0805255, "twoHundredDayAverageChange": -0.024125502, "twoHundredDayAverageChangePercent": -0.29960075, "marketCap": 8045121, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "firstTradeDateMilliseconds": 1608015600000, "priceHint": 4, "regularMarketChangePercent": 4.832712, "regularMarketPrice": 0.0564, "regularMarketChange": 0.0025999993, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.059, "regularMarketDayRange": "0.0538 - 0.059", "regularMarketDayLow": 0.0538, "regularMarketVolume": 1014, "regularMarketPreviousClose": 0.0538, "bid": 0.0562, "ask": 0.0888, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.0538, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.003200002, "fiftyTwoWeekLowChangePercent": 0.060150415, "fiftyTwoWeekRange": "0.0532 - 0.1045", "fiftyTwoWeekHighChange": -0.048100002, "fiftyTwoWeekHighChangePercent": -0.4602871, "fiftyTwoWeekLow": 0.0532, "fiftyTwoWeekHigh": 0.1045, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "tradeable": false, "cryptoTradeable": false, "symbol": "0EH.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Erik Dahlbergsgatan 11A", "city": "Gothenburg", "zip": "411 26", "country": "Sweden", "phone": "46 7 63 19 98 98", "website": "https://www.toleranzia.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also develops TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. Toleranzia AB was incorporated in 2011 and is headquartered in Gothenburg, Sweden.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Ms. Charlotte  Fribert", "age": 55, "title": "CEO & Exec. Director", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Torbj\u00f6rn  Sannerstedt", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Bj\u00f6rn  L\u00f6wenadler", "age": 70, "title": "Chief Bus. Officer", "yearBorn": 1952, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Vidar  Wendel-Hansen M.D., Ph.D.", "age": 63, "title": "Chief Medical Officer", "yearBorn": 1959, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}